首页 / 院系成果 / 成果详情页

Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial.  期刊论文 会议论文  

  • 编号:
    62af176f-4709-4a15-8e0c-1a2e2e4611fd
  • 作者:
    Han, Guohong; Yang, Jijin; Shao, Guoliang; Teng, Gaojun; Wang, Maoqiang; Yang, Jianyong; Liu, Zhaoyu; Feng, Gansheng; Yang, Renjie; Lu, Ligong; Chao, Yee; Wang, Jianhua
  • 语种:
    English
  • 期刊:
    JOURNAL OF CLINICAL ONCOLOGY ISSN:0732-183X 2012 年 30 卷 15 期 ; MAY 20
  • 收录:
  • 推荐引用方式
    GB/T 7714:
    Han Guohong,Yang Jijin,Shao Guoliang, et al. Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial. [J].JOURNAL OF CLINICAL ONCOLOGY,2012,30(15).
  • APA:
    Han Guohong,Yang Jijin,Shao Guoliang,Teng Gaojun,&Wang Jianhua.(2012).Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial. .JOURNAL OF CLINICAL ONCOLOGY,30(15).
  • MLA:
    Han Guohong, et al. "Evaluation of transcatheter arterial chemoembolization (TACE) plus sorafenib in Chinese patients with unresectable hepatocellular carcinoma: A subgroup analysis of START trial." .JOURNAL OF CLINICAL ONCOLOGY 30,15(2012).
浏览次数:2 下载次数:0
浏览次数:2
下载次数:0
打印次数:0
浏览器支持: Google Chrome   火狐   360浏览器极速模式(8.0+极速模式) 
返回顶部